Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: Bioptimus does not list a price
Free plan
Tie
Neither has one
Higher rating
Bioptimus
4.2 against 4.0
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
Bioptimus
Immunai
Our rating
4.2Better
4.0
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Foundation models trained across molecular, cellular and tissue scales
Digital pathology models for research and trial workflows
Transfer learning that reuses existing imaging and omics archives
Benchmarked against independent public evaluations
Research, clinical trial and diagnostics use cases
AMICA-OS platform built on single-cell multi-omic immune system data
Target discovery tools for identifying new drug candidates from immune cell behavior
Preclinical evaluation modeling for testing target hypotheses before trials
Clinical trial optimization using immune-response data
One of the industry's largest clinical immunology datasets, built through 30-plus pharma partnerships
Pros
Cross-scale model design rather than one narrow task classifier
Extracts additional value from data a lab already holds
Published benchmark results give an external reference point
Dataset scale, built through partnerships with Fortune 100 pharma companies, gives its models depth smaller labs can't replicate
Covers the full pipeline from target discovery through clinical trial optimization rather than one narrow step
Named partnerships with AstraZeneca, Boehringer Ingelheim, Pfizer, and Novo Nordisk demonstrate real commercial traction
Cons
Requires in-house validation on local cohorts before clinical reliance
Enterprise-only engagement with no self-serve access
No published pricing; every engagement is a custom partnership negotiation
Built exclusively for pharmaceutical R&D, inaccessible to academic labs or individual researchers without a deal
Value depends on data-sharing arrangements with partners, which take time to negotiate and set up
Company
Bioptimus, founded 2024
Immunai, founded 2018
Prices come from each vendor's pricing page, last checked 20260812. Check the vendor before you buy.
FAQ
Questions people ask
Is Bioptimus better than Immunai?
In our reviews Bioptimus scores 4.2 and Immunai scores 4.0. The better pick depends on the job. Bioptimus: Foundation models for biology spanning molecular, cellular and tissue scales. Immunai: AI platform mapping the human immune system at single-cell resolution to accelerate drug discovery for pharma partners.
Bioptimus
Immunai
